Studies in breast cancer have demonstrated a compelling evidence that BRD4 isoforms have distinct and even contradictive functions [28], providing an insight into mechanisms that are likely at play in other tumor types including ovarian carcinoma. This evidence concerns the gene BRD4 and breast carcinoma.